Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis

JOURNAL ARTICLE published December 2022 in World Journal of Surgical Oncology

Research funded by the Digestive Medical Coordinated Development Center of Beijing Hospitals Authority (XXT01) | the Pilot Project of Clinical Collaboration with Traditional Chinese Medicine and Western Medicine in Major Refractory Disease – Esophageal Cancer (2019-ZX-005)

Authors: Yan Ma | Xiao Ma | Jingting Wang | Shanshan Wu | Jing Wang | Bangwei Cao